Agile Therapeutics | AGRX - Cash And Equivalent


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Agile Therapeutics

Agile Therapeutics reported $4.43M in Cash and Equivalent for its fiscal quarter ending in March of 2023.


Cash And Equivalent Change
Adma Biologics ADMA:US USD 69.2M 17.32M
Agile Therapeutics AGRX:US USD 4.43M 817K
Bayer BAYN:GR EUR 4.85B 317M
BioMarin Pharmaceutical BMRN:US USD 580.07M 144.46M
J&J JNJ:US USD 3.36B 2B
Pacira PCRX:US USD 35.54M 68.59M